Human natural killer lymphocytes directly recognize evolutionarily conserved oligosaccharide ligands expressed by xenogeneic tissues

Transplantation

Volumn 63, Issue 9, 1997, Pages 1318-1330

  Inverardi, Luca ^a,e   Clissi, Barbara ^a   Stolzer, Amy L ^a   Bender, Jeffrey R ^c   Sandrin, Mauro S ^d   Pardi, Ruggero ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d AUSTIN RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; XENOGRAFT; XENOTRANSPLANTATION;

3T3 CELLS; ANIMALS; ANTIBODIES; CELL ADHESION; COS CELLS; ENDOTHELIUM, VASCULAR; EPITOPES; EVOLUTION; GALACTOSYLTRANSFERASES; GRAFT REJECTION; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN G; KILLER CELLS, NATURAL; MICE; OLIGOSACCHARIDES; RECEPTORS, IGG; SWINE; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0030990751     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199705150-00021     Document Type: Article

References (39)

1. Cooper DKC. Xenografting: how great is the clinical need? Xeno 1993; 1: 25.
2. Kaye MP. Registry of the international society for heart and lung transplantation: ninth official report. Heart Lung Transplant 1992; 11: 599.
3. Auchincloss H Jr. Xenogeneic transplantation: a review. Transplantation 1988; 46: 1.
4. Kaufman CL, Gaines BA, Ildstad ST. Xenotransplantation. Annu Rev Immunol 1995; 3: 339.
5. Platt JL, Vercellotti GM, Dalmasso AP, et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 1990; 11: 450.
6. Platt JL, Lindman BJ, Chen H, Spitalnik SL, Bach FH. Endothelial cell antigens recognized by xenoreactive human natural antibodies. Transplantation 1990; 50: 817.
7. Sandrin MS, Vaughan HA, Dabkowsky PL, McKenzie IFC. Antipig IgM antibodies in human serum react predominantly with Galα(1-3)Gal epitopes. Proc Natl Acad Sci USA 1993; 90: 11391.
8. Galili U. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today 1993; 14: 480.
9. Henion TR, Macher BA, Anaraki F, Galili U. Defining the minimal size of catalytically active primate α1,3 galactosyltransferase: structure-function studies on the recombinant truncated enzyme. Glycobiology 1994; 4: 193.
10. Soares MP, Latinne D, Elsen M, Figueroa J, Bach FH, Bazin H. In vivo depletion of xenoreactive natural antibodies with an anti-μ monoclonal antibody. Transplantation 1993; 56: 1427.
11. Leventhal JR, Dalmasso AP, Cromwell JW, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55: 857.
12. Miyagawa S, Shirakura R, Matsumiya G, et al. Prolonging discordant xenograft survival with anticomplement reagents K76COOH and FUT175. Transplantation 1993; 55: 709.
13. Alter BJ, Bach FH. Cellular basis of the proliferative response of human T cells to mouse xenoantigens. J Exp Med 1990; 171: 333.
14. + helper T cells and self antigen presenting cells in the mouse. J Exp Med 1990; 172: 567.
15. Murray AG, Khodadoust MM, Pober JS, Bothwell ALM. Porcine aortic endothelial cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1994; 1: 57.
16. Inverardi L, Pardi R. Early events in cell-mediated recognition of vascularized xenografts: cooperative interactions between selected lymphocyte subsets and natural antibodies. Immunol Rev 1994; 141: 71.
17. Satake M, Korsgren O, Ridderstad A, Karlsson-Parra A, Wallgren AC, Möller E. Immunological characteristics of islet cell xenotransplantation in humans and rodents. Immunol Rev 1994; 141: 191.
18. Inverardi L, Samaja M, Motterlini R, Mangili F, Bender JR, Pardi R. Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. J Immunol 1992; 149: 1416.
19. Inverardi L, Samaja M, Marelli F, Bender JR, Pardi R. Cellular early immune recognition of xenogeneic vascular endothelium. Transplant Proc 1992; 24: 459.
20. Thomas FT, Marchman W, Carobbi A, Araneda D, Pryor W, Thomas J. Immunobiology of the xenograft response: xenograft rejection in the immunodeficient rodents. Transplant Proc 1991; 23: 208.
21. Arakawa K, Akami T, Okamoto M, et al. Prolongation of heart xenograft survival in the NK-deficient rat. Transplant Proc 1994; 26: 1266.
22. White DJ, Oglesby T, Liszewski MK, et al. Expression of human decay accelerating factor or membrane cofactor protein on mouse cells inhibits lysis by human complement. Transplant Proc 1992; 24: 474.
23. Bezouska K, Yuen CT, O'Brien J, et al. Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature 1994; 372: 150.
24. Watson CA, Petzelbauer P, Zhou J, Pardi R, Bender JR. Contact-dependent endothelial class II gene activation induced by NK cells is mediated by IFN-γ-dependent and -independent mechanisms. J Immunol 1995; 154: 3222.
25. Sandrin MS, Dabkovski PL, Hanning MM, Mouhtouris E, McKenzie IFC. Characterization of cDNA clones for porcine α1,3 galactosyltransferase: the enzyme generating the Galα(1,3)Gal epitope. Xenotransplantation 1994; 1: 81.
26. Haisch CE, Lodge PA, Huber SA, Thomas FT. The vascular endothelial cell is central to xenogeneic immune reactivity. Surgery 1990; 108: 306.
27. Sandrin MS, McKenzie IFC. Galα(1,3)Gal, the major xenoantigen(s) recognized in pigs by human natural antibodies. Immunol Rev 1994; 141: 169.
28. Rosen SD. Cell surface lectins in the immune system. Semin Immunol 1993; 5: 237.
29. Ahrens PB. Role of target cell glycoproteins in sensitivity to natural killer cell lysis. J Biol Chem 1993; 268: 385.
30. Drickamer C, Taylor ME. Biology of animal lectins. Annu Rev Cell Biol 1993; 9: 237.
31. Forbes JT, Brethauer RK, Oeltmann TN. Mannose 6-, fructose 1-, and fructose 6-phosphates inhibit human natural cell-mediated cytotoxicity. Proc Natl Acad Sci USA 1981; 78: 5797.
32. Chang C, Rodriguez A, Carretero M, Lopez-Botet M, Phillips JH, Lanier LL. Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol 1995; 25: 2433.
33. Houchins JP, Yabe T, McSherry C, Bach FH. DNA sequence analysis of NK-G2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med 1991; 173: 1017.
34. + activated NK cells. Nature 1992; 358: 66.
35. d, has a functional carbohydrate recognition domain. Immunity 1994; 1: 785.
36. Moretta A, Vitale M, Sivori S, et al. Human natural killer cell receptors for HLA class I molecules: evidence that Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med 1994; 180: 545.
37. Litwin V, Gumperz JE, Parham P, Phillips JH, Lanier LL. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med 1994; 180: 537.
38. Perez-Villar JJ, Melero I, Rodriguez A, et al. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J Immunol 1995; 154: 5779.
39. Wagtmann N, Biassoni R, Cantoni C, et al. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domain. Immunity 1995; 2: 439.